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Introduction: Obstructive sleep apnea and opioid-induced respiratory depression can unpredictably threaten
respiratory competence in the post-anesthesia care unit. Current respiratory monitoring relies heavily on respiratory rate
and oxygen saturation, as well as subjective clinical assessment. These assessments have distinct limitations, and none
provide a real-time, objective, quantitative direct measurement of respiratory status. A novel, non-invasive respiratory
volume monitor uses bioimpedance to provide accurate, quantitative measurements of minute ventilation, tidal volume
and respiratory rate continuously in real time, providing a direct measurement of ventilation.
Case presentation: The case describes an orthopedic surgery patient (54-year-old Caucasian man, body mass index
33.7kg/m2) with diagnosed obstructive sleep apnea in whom the respiratory volume monitor data depicted persistent
apneic behavior undetected by other monitoring. The monitor was able to detect a sudden reduction in minute
ventilation after initial opioid administration in the post-anesthesia care unit. The patient had sustained low
minute ventilation until discharge. Neither respiratory rate data from the hospital monitor nor oxygen saturation readings
reflected the respiratory decompensation, remaining within normal limits even during sustained low minute ventilation.
Conclusions: The events of this case illustrate the limitations of current respiratory rate monitoring and pulse oximetry in
the evaluation of post-surgical respiratory status. Our patient displayed stable respiratory rate and no evidence of
desaturation, despite sustained low minute ventilation, and he received opioids in the post-anesthesia care unit despite
already compromised ventilation. Because the available monitoring did not indicate the patient’s true respiratory status,
he was treated with additional opioids, markedly increasing his risk for further respiratory decline.
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Management of obstructive sleep apnea (OSA) is a
growing concern in peri-operative care. It is estimated
that one in four men and one in ten women have OSA,
with the prevalence among surgery candidates exceeding
that of the general population [1]. Population-based
studies suggest that patients presenting for orthopedic
surgery with OSA are at greater risk for post-operative* Correspondence: christopher.voscopoulos@gmail.com
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unless otherwise stated.pulmonary complications [2,3]. OSA is also substantially
under diagnosed [4,5], and increasing evidence suggests
that classic indicators such as age, body mass index and
patient sex may in fact have little correlation with OSA
prevalence or the manifestation of apnea post-operatively
[6,7]. As a result, assessing individual patient risk for
apnea can be difficult.
Disordered breathing is not the only threat to respira-
tory competence in the post-anesthesia care unit (PACU).
In addition to the effects of surgical insult and anesthesia,
narcotics administered for the management of pain can
lead to opioid-induced respiratory depression (OIRD) or,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A non-invasive respiratory volume monitor (ExSpiron;
Respiratory Motion, Inc.) that provides continuous, real-time,
non-invasive measurements of minute ventilation, tidal volume
and respiratory rate. This photograph shows standard electrode
placement on an obese patient (not the patient reported here;
body mass index, 36.7kg/m2). One electrode is placed at the sternal
notch, another on the xiphoid and the third in the right mid-axillary
line at the level of the xiphoid.
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opioid-induced ventilatory insufficiency (OIVI) [8,9].
The potential synergy between unpredictable apneic and
hypopneic events and OIVI is a significant threat to patient
safety. Care providers typically rely on a combination of
oxygen saturation, respiratory rate (RR) and subjective clin-
ical assessment to evaluate respiratory status in the PACU,
but these are only surrogate indicators of ventilatory drive.
Without a direct, objective measurement of ventilation,
clinical personnel cannot accurately quantify the effects of
disordered breathing or drug administration on respiratory
sufficiency. There is a need for a cost-effective, evidence-
based, real-time solution to these challenges.
A novel, non-invasive respiratory volume monitor (RVM)
has been developed that produces continuous digital
volume traces and accurately reports minute ventilation
(MV), tidal volume (TV) and RR in non-intubated
patients. Continuous MV measurements provide direct
assessment of respiratory function and can quantify
apnea and respiratory deterioration in real time. Use of
RVM technology is consistent with current American
Society of Anesthesiologists guidelines for monitoring
of ventilation in the PACU [10] and can provide health
care professionals with a more complete assessment of
respiratory status.
Here we report a case of a patient who experienced a
substantial reduction in ventilation in response to a single
opioid dose in the PACU. RR and pulse oximetry were
insufficient to detect the potential threat to patient safety.
Case presentation
A 54-year-old Caucasian man (weight, 116kg; height,
185cm body mass index, 33.7kg/m2) underwent left total
hip replacement surgery under general anesthesia. A
bioimpedance-based RVM (ExSpiron, Respiratory Mo-
tion, Inc., Waltham, MA, USA) was used to collect
digital respiratory traces via an electrode PadSet placed
on the thorax (Figure 1), beginning pre-operatively and
continuing until PACU discharge, for a total of 418 minutes
(106 minutes pre-operatively, 192 intra-operatively and 120
minutes in the PACU). MV, TV and RR measurements
were calculated every 5 seconds for the duration of this
period from 30-second segments collected in a sliding win-
dow. The clinical staff were blinded to RVM data. Vital sign
measurements and pulse oximetry readings were obtained
as part of routine patient care and were available to care-
givers for ongoing patient management.
The patient’s past medical history was positive for
OSA, with no other respiratory conditions. The patient
owned a home model of a continuous positive airway
pressure (CPAP) device but had not been using it. In the
pre-operative holding area, the patient was very sleepy,
though not yet sedated. The RVM trace showed sustained,
visible manifestations of apnea over this period (Figure 2B).Clinical personnel had no way to observe these apneic
episodes and were unaware of the patient’s disordered
breathing. No snoring or physical indications of ob-
struction were observed. The patient was taken to the
operating room, where sedation was induced with 300mg
of propofol and 250μg of intravenous (IV) fentanyl and
intubated after receiving 50mg of IV rocuronium. Two
0.5mg doses of hydromorphone were administered in the
15 minutes after incision, along with three additional
doses of rocuronium (20mg, 10mg, 10mg) over the subse-
quent hour. Surgery lasted 134 minutes, after which the
patient was extubated and transferred to the PACU.
Within 20 minutes of PACU arrival, prior to receiving
any post-operative opioids, the patient began to exhibit
apneic events lasting up to 45 seconds (Figure 2C). As in
pre-operative holding, no outward indications of disor-
dered breathing were observed. Using a standard formula
based on ideal body weight [11], the patient’s predicted
minute ventilation (MVPRED), expected to be sufficient to
maintain blood oxygen and carbon dioxide levels under
baseline conditions, was calculated to be 7.9L/min. Pre-
vious research has described ventilation below 80% of
MVPRED prior to opioid administration as putting a pa-
tient at risk for OIRD (MV <40% of MVPRED), a potential
threat to patient safety [7]. Our patient’s average MV, as
measured by the RVM during the 5 minutes of stable
breathing prior to an initial PACU opioid administration,
was 3.70L/min, 44% of MVPRED.
Figure 2 Two-minute captures of traces from a bioimpedance-based respiratory volume monitor over the course of the peri-operative stay, with
average minute ventilation, tidal volume and respiratory rate. (A) Normal pre-operative breathing. (B) Pre-operative apnea. (C) Apnea prior to
opioid administration in the post-anesthesia care unit (PACU). (D) Reduced ventilation with obstructed breathing after an initial opioid administration.
Predicted minute ventilation (MVPRED) based on ideal body weight for the patient was 7.9L/min. (E) Time course of the patient’s minute ventilation
(MV) over his entire PACU stay. Dashed horizontal lines represent (from top to bottom) 100%, 80% and 40% of MVPRED. Purple lines indicate opioid
administrations (hydromorphone). Ventilation decreased following opioid administration and was persistently low until discharge. Respiratory rate (RR)
and oxygen saturation levels, as documented by clinical personnel in the PACU flowchart, are shown below. (F) Mean and standard deviation for MV
measurements recorded by the respiratory volume monitor (RVM) during 5 minutes of patient rest before and after an initial opioid administration
(15:32) in the PACU (periods shown in gray in (E)). The RVM data depict a sudden drop in ventilation that is not reflected in either RR or oxygen saturation
levels. TV, Tidal volume.
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administered dose of hydromorphone (0.4mg). This was
followed by an immediate reduction in ventilation, withaverage MV of only 2.37L/min (28% of MVPRED) in the
subsequent 5 minutes (Figure 2F). The patient’s RR gave
no indication of compromise, remaining between 12 and
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and even showing a slight increase after hydromorphone
administration (Figure 2E). Blinded to the RVM data
and with no way to objectively evaluate ventilation, clinical
personnel continued to administer opioids to manage pain
in accordance with standard practice. The patient re-
ceived a second nurse-administered hydromorphone dose
(0.4mg) 40 minutes after the first. He was then provided
with a patient-controlled analgesia (PCA) device and re-
ceived three PCA doses (0.2mg hydromorphone each) in
under 1 hour, before being discharged to a general care
unit 118 minutes after PACU arrival (Figure 2E). MV
remained low (<40% MVPRED) for the duration of the pa-
tient’s PACU stay and was still reduced upon discharge.
RVM monitoring was discontinued at that time.
Discussion
The events of this case illustrate the limitations of RR
monitoring and pulse oximetry in the evaluation of post-
surgical respiratory status. With a stable RR and no evi-
dence of desaturation, our patient received opioids in the
PACU in spite of already compromised ventilation. The
compromised ventilation was not able to be immediately
appreciated by clinical personnel. RR and oxygen saturation
provided no forewarning of potential respiratory insuffi-
ciency, and the patient was treated with additional opioids,
markedly increasing the risk for further respiratory decline.
The patient was discharged to a general hospital floor
without indication of the need for continuous respira-
tory monitoring, despite sustained low ventilation and
additional opioid doses in the closing minutes of his
PACU stay. Fortunately, he experienced no adverse events.
All clinical decisions in this case were made according
to standard protocols. Any potential threat to patient
safety was not the result of substandard care, but rather
was due to inherent pitfalls in established respiratory
monitoring technology and practice. In this case, the
commonly used respiratory monitoring (RR and peripheral
capillary oxygen saturation) did not suggest respiratory
compromise, despite persistent low MV after opioid ad-
ministration. If RVM data had been available, the pa-
tient’s initial respiratory depression would have been
noted and the patient’s opioid regimen might have been
adjusted or a multimodal approach to analgesia might
have been pursued. Low MV readings and an RVM trace
demonstrating disordered breathing characteristics might
have led to the utilization of CPAP. Also, decreased MV at
the time of discharge might have led clinical personnel to
delay transfer to the floor or triage the patient to a step-
down unit or monitored bed.
RR and pulse oximetry are only surrogate indicators of
ventilatory drive. RR, as this case illustrates, does not reli-
ably provide an accurate picture of overall ventilation, as it
does not adequately reflect variations in tidal volume. Pulseoximetry has well-documented issues with reliability and
false alarms in the clinical setting and represents at best
only the end result of respiration [12-14]. As a result, there
can be a substantial delay between onset of respiratory
compromise and a detectable decline in oxygen saturation
levels [12,13].
By comparison, the RVM’s reliable, continuous tracking
of MV allows direct assessment of ventilatory drive in real
time. Health care providers can quantify ventilation status
on arrival to the PACU, recognize apnea, evaluate reduc-
tions in ventilation after opioid dosing, and prevent per-
sistent respiratory compromise over the course of a PACU
stay. The increased awareness afforded by the RVM facili-
tates the initiation of more timely interventions. Clinical
personnel can modify opioid regimens, pursue alternative
pain management strategies, or initiate CPAP or bilevel
positive airway pressure. The RVM data also provide a
valuable context for discharge and triage decisions, help-
ing clinical personnel to avoid premature transfer and to
select an appropriate acuity level for subsequent care.
Individualization of the pain management regimen in the
PACU and the ability to relay quantitative measurements
upon transfer to the floor has the potential to enhance
patient safety.
RVM technology may also have applications in pre-
operative screening. Caregivers may have elected to manage
the patient described in this report differently had they
been able to identify and quantify the apnea exhibited
prior to surgery. As discussed earlier, OSA presents a
number of challenges to peri-operative care. The preva-
lence of OSA and its association with post-operative
complications has led the American Society of Anesthe-
siologists and similar organizations to release guidelines
calling for prolonged post-surgical observation of patients
with OSA [15]. Hospitals are left with a management
dilemma. Ignoring OSA may pose a threat to patient
safety and lead to the involvement of costly higher acuity
services, but generalized management programs can be
cost-prohibitive as well and are potentially inefficient
solutions. Non-invasive, real-time, continuous respiratory
volume monitoring allows for direct, comprehensive as-
sessment of individual ventilation during peri-operative
care. This technology can contribute to continuing im-
provement of patient-specific protocols for the manage-
ment of OSA, OIRD and other phenomena that pose a
threat to respiratory competence in the aftermath of
surgery.
Conclusions
The events of this case illustrate the limitations of
current respiratory rate monitoring and pulse oximetry
in the evaluation of post-surgical respiratory status. Our
patient displayed stable respiratory rate and no evidence
of desaturation, despite sustained low minute ventilation,
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despite already compromised ventilation. Because the
available monitoring did not indicate the patient’s true
respiratory status, he was treated with additional opioids,
markedly increasing his risk for further respiratory
decline. Using the additional information provided by
the RVM, care providers would be able to optimize post-
operative care and improve patient safety.
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